More broadly, increasing our knowledge of the regulation of PrP gene expression may help design novel strategies for therapeutic intervention in cancer, beyond directly targeting PrPC through antisense oligonucleotides (Meslin et al., 2007) or monoclonal antibodies (Du et al., 2013). This evidence concerns the gene PRNP and cancer.